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ABSTRACT  
 
Objective: The objective of this selective EBM review is to determine whether or not PRP 
injections are more effective in decreasing chronic lower back pain as compared to epidural 
injections in young adults.  
 
Study Design: Systematic review of three English language randomized controlled trials (RCTs), 
all published after 2012. 
 
Data Sources: Two double-blind RCTs and one randomized open blinded end point (PROBE), 
which analyzed the effectiveness of PRP and epidural injections in young adults with chronic 
lower back pain.  All studies were found using PubMed. 
 
Outcome(s) Measured: Each of the articles analyzed the pain relief and function ability stated by 
the patient post PRP injections and epidural injections. These outcomes were measured using the 
visual analog scale score (VAS), the average of Numeric Rating Scale (NRS), the Oswestry 
Disability Index (ODI), the Modified Oswestry Disability questionnaire (MODQ), and the 
Functional Rating Index (FRI). Significance was determined using p-values for all three studies.  
 
Results: Manchikanti et al. (2014) found that there was no significant difference between the use 
of local anesthetic alone compared to local anesthetic and steroid when treating chronic lower 
back pain in regards to pain and function measured by NRS and ODI scores. Singla et al. (2017) 
found that the pain significantly decreased at 6 weeks in patients treated with PRP injections 
compared to the group treated with steroid injections. This study also showed that the efficacy of 
PRP injections at 3 months was 90% compared to only 25% in the group with steroid injections. 
Tuakli-Wosornu et al. (2016)  found that patients treated with PRP injections showed statistically 
significant improvements in pain and function 8 weeks post-procedure in regards to NRS best 
pain and FRI score. 
 
Conclusions: the results from the three randomized controlled studies demonstrated that PRP 
injections are more effective in decreasing chronic lower back pain compared to epidural steroid 
injections by having less procedures, less adverse effects and providing lasting pain relief.  
 
Key words: chronic lower back pain, platelet rich plasma, steroid injections.  
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INTRODUCTION    
Low back pain is a very common condition in adults. Approximately, 80% of adults 
experience at least one episode of low back pain during their lifetime and approximately 20% of 
these patients have another episode within six months.1 According to the National Institute of 
Neurological Disorders and Stroke “back pain is caused by general degeneration of the spine 
associated with normal wear and tear that occurs in the joints, discs, and bones of the spine as 
people get older” The cause of low back pain is very complex, although the most common cause 
is degenerative changes in the lumbar spine.2  
This condition is the most common cause of disability among Americans between 45 and 
65 years of age;1 and it is the second most common cause of primary care visits.3 The cost of 
lumbar epidural steroid transforaminal treatment based on setting arrangement is between $2,600 
to $3,000 per year.1 Therefore making it difficult for patients who do not have health insurance 
coverage to afford these treatments.  Today, low back pain is estimated to be the third largest 
condition of health care spending at $87.6 billion.4 
Aside from plasma rich platelet injections there are several non-invasive methods to treat 
low back pain such as acupuncture, physical therapy, physiotherapy, NSAIDs and opioids. In 
addition, there are other treatments that are more invasive such as radiofrequency neurotomy, 
epidural steroid injections, and if all these fail, then surgery. The three studies that will be 
discussed are recent RCTs that evaluate the efficacy of plasma rich platelet injections compared 
to epidural steroid injections. 
Plasma rich platelets (PRP) is a biological blood-derived product that can be injected to 
various tissues since it releases high concentrations of platelet-derived growth factors that 
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enhance the body’s natural healing process.2 However, there is very little research on the topic 
due to the lack of standardization of graft preparation. 3 
OBJECTIVE 
The objective of this selective EBM review is to determine whether or not PRP injections 
are more effective in decreasing chronic lower back pain as compared to epidural injections in 
young adults.   
METHODS 
All three articles were obtained via a search of the PubMed database using the keywords 
chronic lower back pain, platelet rich plasma, and steroid injections. Only randomized control 
trials published after 2012 were selected, based on the relevance and the importance of outcome 
to the patient. The articles chosen were published in English in peer-reviewed journals. Inclusion 
criteria included randomized controlled trial prospective studies; and they included patients who 
were at least 18 years old with chronic lower back pain for more than three months treated with 
either PRP or steroids injections in the lumbar area below L3. Exclusion criteria included 
patients who used PRP in another joints or tissues.  
This review is comprised of a set of three randomized controlled trials that were selected 
based on relevance and patient oriented evidence that matter (POEMs). Manchikanti et al.1 used 
a RCT double blind study to compare two groups. Group I received lidocaine and a sodium 
chloride solution while group II received lidocaine plus betamethasone. The outcomes measured 
were pain relief and functional status using Numeric Rating Scale (NRS) and the Oswestry 
Disability Index (ODI). Singla et al.2 used a prospective randomized open blinded end-point 
study (PROBE) to compare two groups. Group S received methylprednisolone and lidocaine 
while group P received leukocyte-free PRP and calcium chloride. The outcomes measured were 
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intensity of pain and functional disability with visual analog scale (VAS) and Modified Oswestry 
Disability Questionnaire (MODQ). Tuakli-Wosornu et al.3  used a double-blind RCT to compare 
intradiscal PRP injections vs. a contrast agent. The outcomes measured were improvement in 
pain and function with Functional Rating Index (FRI) and Numeric Rating Scale (NRS). All 
three of the studies determined significance using p-values.1,2,3 A summary of the demographics 
of each study can be found in Table 1 below. 
Table 1: Demographics and Characteristics of Included Studies. 
STUDY TYPE # 
PTS 
AGE 
(yrs) 
Inclusion criteria Exclusion criteria W
/D 
Interventions 
Manchika
nti, 20141  
Double 
blind 
RCT 
120 43 ± 
12 
years 
- Pts who were at least 
18 y/o with chronic 
lower back pain and 
lower extremity pain of 
at least 6 months, only 
disc herniations at L4-
L5 and L5-S1, all pts 
must have PT along with 
exercise program and 
nonsteroidal anti-
inflammatory therapy.  
- Hx of previous lumbar 
surgery, radiculitis w/o 
disc herniations, pts 
with B/L radiculopathy, 
radiculitis secondary to 
spinal stenosis, and pts 
with other uncontrolled 
medical illnesses.  
0 Group 1 
received local 
anesthetic with 
saline whereas 
pts in group 2 
received local 
anesthetic and 
steroid. 
Singla, 
20172  
Open 
blind 
RCT 
40 18-65 - Pts of either sex with 
chronic low back pain 
(predominantly below 
the L5 vertebra) of 
moderate intensity for > 
3 months, Pts having 
unilateral SIJ pathology 
on X-ray, magnetic 
Patients having 
unilateral SIJ pathology 
on X-ray, MRI, or 
nuclear scan with 3 or 
more positive 
provocative tests.  
- Systemic infection or 
localized infection at 
the anticipated 
introducer entry site, 
spinal pathology that 
may impede recovery, 
pregnancy, Active 
radicular pain,        
Immunosuppressive 
conditions, allergy to 
medications used in the 
procedure; narcotic use, 
contraindications 
pertaining to the use of 
platelet concentrate. 
0 A mixture of 
2% lidocaine 
with 
methylprednisol
one or PRP with 
calcium 
chloride. 
Tuakli-
Wosornu, 
20163 
Double 
blind 
RCT 
51 44 ± 
9 
years 
- Refractory low back 
pain persisting for > 6 
months, failure of 
conservative treatment 
measures, maintained 
intervertebral disk height 
of at least 50%, disk 
- Presence of a known 
bleeding disorder, 
current anticoagulation 
therapy  ,pregnancy  , 
systemic or skin 
infection over the 
puncture site, allergy to 
4  A single 
Intradiscal PRP 
injection vs. 
visualized 
matched 
placebo 
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protrusion less than 2 
mm on MRI or CT, 
concordant pain on 
discography, presence of 
a grade 3 or 4 annular 
fissure as determined by 
discography, Absent 
contraindications (eg, 
spinal stenosis)  
contrast agent, presence 
of a psychiatric 
condition, solid bone 
fusion preventing 
access to the disk, 
severe spinal canal 
compromise at the 
levels to be 
investigated, extrusions 
or sequestered disk 
fragments, previous 
spinal surgery, 
spondylolysis, 
spondylolisthesis. 
 
 
OUTCOMES MEASURED 
The outcomes measured in each of the three studies were functional ability and back pain 
relief. Both are considered patient-oriented outcomes because they significantly impacted a 
patient’s quality of life. Manchikanti et al.  measured pain with the Numeric Rating Scale (NRS) 
and also measured functional ability with the Oswestry Disability Index (ODI).1 These were 
measured at 3,6,12,18, and 24 months. This study also measured secondary outcomes such as 
opioid intake, employment, and work status among both groups, but were not examined in this 
review. 
Singla et al. measured the pain intensity with the visual analog scale (VAS) from pre-
injection to follow-ups in both groups at 2,4,6 weeks and 3 months.2 The disability of the patient 
was measured by Modified Oswestry Disability Questionnaire (MODQ) score. These were also 
measured at 2,4,6 weeks and 3 months. This study also compared post-injection complications 
among both groups, but these were not examined in this review. 
Tuakli-Wosornu et al. measured function and pain related with Functional Rating Index 
(FRI) and Numeric Rating Scale (NRS).3 This study also measured secondary outcomes among 
both groups, but these were not examined in this review. 
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RESULTS 
In the study by Manchikanti et al.1, 120 patients with chronic low back pain and with disc 
herniations at levels L4-L5 and L5-S1 were enrolled. Patients were assigned randomly via 
computer to two groups with 60 patients in each group: Group I was treated with 1.5 ml of 
preservative-free lidocaine 1% followed by a 0.5 ml sodium chloride solution, while group II 
was treated with preservative-free lidocaine 1% followed by 3 ml of betamethasone. All patients 
continued drug therapy with opioids or nonsteroidal anti-inflammatory drugs at a lower dose. All 
the injections were performed by one physician in an interventional pain management center 
based on Consolidated Standards Reporting Trials (CONSORT) guidance. An intention to treat 
analysis was used when data was missing or unavailable. At baseline, both groups had similar 
clinical characteristics with no statistical differences regarding the NRS and ODI as described in 
table 2. This study showed that there is no superiority from using steroids injections over 
lidocaine injections for low back pain. Both showed significant and similar improvement of at 
least 50% in pain and function in responsive patients. In addition, at 2 years, 65% of patients 
who received lidocaine alone showed improvement in comparison to 57% who received steroids. 
Table 2: Comparison of NRS and ODI at baseline and at 2 years. 
 
Time Points Numeric Pain Rating Scale Oswestry Disability Index 
 Group I 
Mean ± SD 
Group II 
Mean ± SD 
Group I 
Mean ± SD 
Group II 
Mean ± SD 
Baseline 8.3 ± 0.9 8.2 ± 0.9 29.9 ± 4.8 28.0 ± 5.3 
24 months 4.0* ± 1.6  
 
4.2* ± 1.6 
 
14.9* ± 6.9 
 
14.1* ± 6.5 
 
* significant difference with baseline values within the group (P <0.001) 
Manchikanti et al. Transforaminal epidural injections in chronic lumbar disc herniation - a 
randomized, double blind, active control trial. 
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Table 3: Efficacy of lidocaine injections compared lidocaine with steroid injections at 2 years. 
CER EER RBI ABI NNT 
0.7 0.6 -0.14 -0.01 -10 
 
Local adverse events including 28 (4.6%) intravascular infiltrations and 9 (1.5%) nerve 
root irritations were obtained during the entire the study. 
In the study by Singla et al.,2 forty patients were selected who met the criteria between 
the ages of 18 and 65 years old with chronic low back pain predominantly below L5.  Patients 
were assigned randomly via computer to two groups with 20 patients in each group. Group S was 
treated with 1.5 ml of methylprednisolone and 1.5 ml of 2% lidocaine with 0.5 ml of saline, 
while Group P received 3 ml of leukocyte-free PRP with 0.5 ml of calcium chloride. All pain 
medications were discontinued, including NSAIDs, before the start of this study. The injections 
were administered only once and patients followed up at 2,4,6 weeks and 3 months. Data 
analysis was performed using Statistical Package for the Social Sciences version 20. All tests 
were evaluated for 95% confidence limits. A P-value of less than 0.05 was considered as 
statistically significant. At the baseline parameters, both groups had similar clinical 
characteristics with no statistical differences regarding the VAS score, this held true at both 2 
weeks and 4 weeks according to the study. At three months, the percentage of pain free in group 
P was 90% compared to 25% in group S. The MODQ scores were very similar in both groups at 
pre-injection, 2 weeks and 4 weeks; however, at 6 weeks and 3 months it was much lower in 
Group P compared to Group S as expressed in this article.  No major post-injections 
complications were reported in any of the groups other than temporary pain and stiffness in 
Group P that subsided within 2 days of onset. The odds of achieving reduction in VAS >50% 
from baseline in group P were 10.91 times higher than in group S at 6 weeks, and 37.28 times 
higher at 3 months as described in table 5.2 
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Table 4: Efficacy of PRP injections compared to steroid injections at 3 months. 
CER EER RBI ABI NNT P-value 
0.3 0.9 2.6 -0.67 2 0.01 
 
Table 5: Patients with reduction of VAS at different times (pain reduction) and MODQ (disability) 
Time Points VAS  MODQ P-
value 
95 % CI 
 Group P Group S  Group P Group S   
2 weeks 12 (60 %) 15 (75%) Baseline 48 % 45 %  
0.001 
 
27.0 – 
159.66 3 months  18 (90 %) 5 (25 %) 3 months 28 % 14 % 
   
In the study by Tuakli-Wosornu et al.,3 forty-seven patients were studied who had 
refractory low back pain for longer than 6 months with the presence of grade 3 or 4 annular 
fissure (< 2ml) seen in discography. The treatment group included 29 participants while the 
control group included 18 participants. The treatment group received 3-4 ml of PRP while the 
control group received 1-2 ml of contrast agent. A P-value of less than 0.05 was considered as 
statistically significant. These injections were administered only once and patients were analyzed 
at baseline, 1 week, 4 weeks, and 8 weeks. In addition, twenty eight patients came back at 6 
months for follow up and 21 patients came back a year later for a last follow up. At baseline 
there was no significant difference between both groups. At the 8 week follow up, the 
comparisons between both groups demonstrated significant improvement in the PRP group 
compared to the control group regarding the FRI score (P= 0.03)  and the NRS (P=0.02). Fifty 
six percent of the patients treated with PRP were satisfied with the treatment compared to 18% of 
the patients in the control group. No complications were reported in either group. 
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Table 6: Efficacy of PRP injections compared to placebo group at 8 weeks.  
CER EER RBI ABI NNT P-value 
0.18 0.56 2.1 0.38 3 0.01 
Table 7: Comparison of NRS (best pain) and FRI score at baseline and at 8 weeks.  
 
Time Points Numeric Pain Rating Scale Functional Rating Index P-value 
 Control 
Mean ± SD 
PRP 
Mean ± SD 
Control 
Mean ± SD 
PRP 
Mean ± SD 
NRS  FRI 
Baseline 2.08 ± 1.7 2.81 ± 1.8 45.37 ± 15.6 51.47  ± 15.6   
8 weeks 2.72  ± 2.1  2.00 ± 2.1 44.45 ± 19.6 37.99  ± 19.6 0.03 0.02 
 
At 6 months NRS P=0.01, FRI P= 0.01. At 1 year NRS P=0.01, FRI P= 0.01  
 DISCUSSION 
Steroid injections have been commonly used to treat chronic lower back pain, but usually 
the patient needs to have several injections done in order to experience pain reduction of at least 
50%.1 PRP is a relatively new procedure that holds promise given the need for fewer procedures 
and longer lasting pain relief, however, this procedure is not yet covered by health insurance 
companies.5 According to Dr. Verma, an orthopedic surgeon, the average price of a single PRP 
injection is $750. Patients with lower back pain often may need more than one injection in one 
procedure.5 This causes a major limitation for patients since they have to pay out of pocket for 
this procedure. In 2013, Hsu et al. reported that PRP is more expensive than steroid injections 
when used in short-term treatment, but less expensive when used for long-term treatment.6 
According to the FDA guidelines, PRP injections have not been approved by the FDA 
since it does not follow the regulatory pathway that includes animal and clinical trials. However, 
it has clearance from the Center for Biologics Evaluation and Research (CBER), a provider of 
the FDA, to be used to mix with bone graft materials to enhance bone graft handling in 
orthopedic practices. Therefore, if PRP is used outside that setting, it would be considered “off 
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label” which means that the clinician can use them as long as they are well informed about the 
product and its scientific rationale, as well as to maintain records of its use and side effects.7 
This systematic review of three randomized controlled trials analyzed the efficacy of PRP 
injections compared to steroid injections regarding long lasting back pain relief. In the study by 
Singla et al.,2 the follow-up duration was very short with respect to evaluating if chronic lower 
back pain could have long-lasting pain relief. A longer follow-up of at least 2 years is suggested. 
In addition, this study was open-blinded, which could result in bias.  In the study by Manchikanti 
et al., 1 all patients continued taking drug therapy with opioids or NSAIDS, so the results might 
not be due to the steroids. However, the major limitation of this study it was that the steroids 
were compared to a placebo instead of PRP. In the study by Tuakli-Wosornu et al.,3 the major 
limitation was the short follow-up time of the placebo group lasting 8 weeks.  
Finally, regarding possible complications of PRP injections showed no complications, 
only temporary pain and stiffness with 2 days post-procedure.2  
CONCLUSION 
Based on the information obtained from these three randomized controlled studies, both 
injections demonstrated efficacy in low back pain relief. However, platelet rich plasma injections 
demonstrated to be more effective over steroid injections in decreasing chronic back pain and 
improving functional ability with lasting results and less adverse effects in adults in two studies. 
Future studies may benefit from a longer follow up time such as 2 years. They may also benefit 
from a comparison of baseline lumbar MRI versus last follow up MRI to compare if there is any 
difference in regards to disc heights pre and post treatment.  
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